MedTrace Logo

Prevalence of Thrombophilic Gene Polymorphism (MTHFR C677T) in COVID-19patients

NCT05679414 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 46

Last updated 2023-01-11

No results posted yet for this study

Summary

Aim of the study is to find the prevalence of thrombophilic gene methylene tetrahydrofolate reductase (MTHFR) gene polymorphism in a sample of COVID-19 patients, aiming at early detection of MTHFR mutant patients and guiding preventive therapy.

Conditions

  • COVID 19 Associated Coagulopathy

Interventions

DIAGNOSTIC_TEST

RT- PCR of 2 ml EDTA blood sample to determine MTHFR C677T genotypes

Venous blood sample

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Eman B AbdelFattah, MD · Ain Shams University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-11
Primary Completion
2022-11-30
Completion
2022-11-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05679414 on ClinicalTrials.gov